Pulmonary Fibrosis Trust Welcomes Approval of New Drug

nerandomilast (Jascayd)

THE Pulmonary Fibrosis Trust has welcomed the approval of nerandomilast (Jascayd) by the Medicines and Healthcare products Regulatory Agency (MHRA), describing it as an important milestone for thousands of people living with pulmonary fibrosis across the UK…

Read the full article here

Related Posts

Posted in category: About Pulmonary Fibrosis Posts

Fixing lung health in the UK

09 May 2024

Saving Your Breath

18 November 2023